Home / Pharmaceutical company intelligence
Panacea Pharmaceuticals logo
Pharmaceutical company intelligence

Panacea Pharmaceuticals

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Pharmaceutical manufacturer · Islamabad · Pakistan

Islamabad/Rawat pharmaceutical manufacturer producing tablets, liquids, ointments and injectables for the national market.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation26 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date20 Aug 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Panacea Pharmaceuticals Pakistan
Company type
Pharmaceutical manufacturer
Address
Plot 4, Street S-6, National Industrial Zone, Rawat, Islamabad, Pakistan
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
88%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000600 Panacea Pharmaceuticals. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000600 111 linked products · source seen 26 Sep 2026 View source ↗
Corporate profile source ledger Logo Url source ↗ Contact Page Url source ↗ Logo Source Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx123public portfolio records represented
REG100unique registrations represented
IDX111indexed MedInfoBase presentations
SRC2additional source-observed presentations
R+10registry-only registrations
VER10registry-verified exact registrations
PKR111current validated price records
G43generic molecules in indexed catalogue
DF7dosage-form groups
TA10therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage90%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage96%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixPanacea PharmaceuticalsShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/panacea-pharmaceuticalsGenerated 26 Sep 2026Anti-infectives61 · 55%CNS & mental health24 · 22%Gastrointestinal & hepatology7 · 6%Cardiovascular4 · 4%Hematology & thrombosis4 · 4%Vitamins, minerals & nutrition3 · 3%Reproductive & genitourinary2 · 2%Other therapeutic areas6 · 5%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioPanacea PharmaceuticalsDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/panacea-pharmaceuticalsGenerated 26 Sep 2026111presentationsTablet64 · 58%Capsule20 · 18%Suspension14 · 13%Drops5 · 5%Cream4 · 4%Gel3 · 3%Other forms1 · 1%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionPanacea PharmaceuticalsCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/panacea-pharmaceuticalsGenerated 26 Sep 2026107comparable productsBelow peer median20 · 19%Near peer median44 · 41%Above peer median43 · 40%Company median price position+4.2%Lowest-price equivalents8Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsPanacea PharmaceuticalsCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/panacea-pharmaceuticalsGenerated 26 Sep 2026Nabiqasim Industries (Pvt) Ltd.,32 shared74% overlapCCL Pharmaceuticals (Pvt.) Limited28 shared65% overlapHIGH-Q Pharmaceuticals28 shared65% overlapGenome Pharmaceuticals (Pvt.) Ltd.28 shared65% overlapM/s. Genix Pharma (Pvt) Ltd.27 shared63% overlapBosch Pharmaceuticals (Pvt) Ltd.26 shared60% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives61 products · 55%
CNS & mental health24 products · 22%
Gastrointestinal & hepatology7 products · 6%
Cardiovascular4 products · 4%
Hematology & thrombosis4 products · 4%
Vitamins, minerals & nutrition3 products · 3%
Reproductive & genitourinary2 products · 2%
Ophthalmology2 products · 2%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Antipsychotics16 products · 14%
Fluoroquinolone antibacterials15 products · 14%
Macrolide antibacterials13 products · 12%
Antimalarials9 products · 8%
Antifungals7 products · 6%
Proton pump inhibitors6 products · 5%
Antiparasitic medicines4 products · 4%
Third-generation cephalosporins4 products · 4%
Formulation footprint

Dosage forms

Tablet64 products
Capsule20 products
Suspension14 products
Drops5 products
Cream4 products
Gel3 products
Injection1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 QUTECQuetiapine 7presentations 100 mg, 200 mg, 25 mg · Tablet #2 NEEDOXCiprofloxacin 5presentations 0.3 %, 125 mg/5 mL, 250 mg, 250 mg/5 mL · Drops, Suspension, Tablet #3 ZITHINAzithromycin 5presentations 200 mg/5 mL, 250 mg, 500 mg · Suspension, Tablet #4 APROClarithromycin 4presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL, 500 mg · Suspension, Tablet #5 GAMPOmeprazole 4presentations 20 mg, 40 mg · Capsule #6 LEVINLevofloxacin 4presentations 125 mg/5 mL, 250 mg, 500 mg, 750 mg · Suspension, Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median2019% of comparable products
Near market median44within ±5% of median
Above market median4340% of comparable products
Lowest-price equivalents8ties included
Company median price position +4.2% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
METRONOL 0.75 %Metronidazole (Benzoate) · Gel · 15gm PKR 5.35/g-74.8% vs market median METRONOL 0.75 %Metronidazole (Benzoate) · Gel · 25gm PKR 5.78/g-72.8% vs market median NEEDOX 125 mg/5 mLCiprofloxacin · Suspension · 60ml PKR 2.00/mL-43.5% vs market median NEEDOX 250 mg/5 mLCiprofloxacin · Suspension · 60ml PKR 3.44/mL-33.5% vs market median AMEPINE 5 mgAmlodipine · Tablet · 20 PKR 7.23/tablet-33.4% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 32shared generics CCL Pharmaceuticals (Pvt.) Limited249 products · 99 generics 28shared generics HIGH-Q Pharmaceuticals215 products · 61 generics 28shared generics Genome Pharmaceuticals (Pvt.) Ltd.181 products · 84 generics 28shared generics M/s. Genix Pharma (Pvt) Ltd.297 products · 97 generics 27shared generics Bosch Pharmaceuticals (Pvt) Ltd.258 products · 74 generics 26shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers89Distinct registrations among indexed, published, presentation-validated products only
Verified price observations222
Products with a verified price111
Products with multiple price observations111
Source records with multiple versions111
Latest portfolio source check22 Sep 2026
Latest effective price date20 Aug 2026
Latest source observation26 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

100 unique registration(s) · 111 indexed presentation(s) · 2 additional source-observed presentation(s) · 10 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
LUMETHER DS Artemether + Lumefantrine 80 mg + 480 mg Capsule 4 060131 PKR 454.37 PKR 113.59/capsule Near median
LUMETHER FORTE Artemether + Lumefantrine 40 mg + 240 mg Capsule 8 060130 PKR 545.24 PKR 68.16/capsule 8% above median
Magfast 40mg InjectionRegistry verified Omeprazole as Sodium — — — 131908Official source ↗ No indexed price — —
MAGSER Omeprazole 20 mg Tablet 14 059426 PKR 297.40 PKR 21.24/tablet 12% above median
MAGSER Omeprazole 40 mg Tablet 14 060286 PKR 516.33 PKR 36.88/tablet 14% above median
Mectin Ivermectin 3 mg Tablet 20 075025 PKR 660.90 PKR 33.05/tablet Near median
Mectin Ivermectin 6 mg Tablet 10 075026 PKR 547.30 PKR 54.73/tablet Near median
METRONOL Metronidazole (Benzoate) 0.75 % Gel 25gm 111086 PKR 144.52 PKR 5.78/g 73% below median
METRONOL Metronidazole (Benzoate) 0.75 % Gel 15gm 111086 PKR 80.29 PKR 5.35/g 75% below median
MOXOLENE Moxifloxacin 400 mg Tablet 5 050178 PKR 981.02 PKR 196.20/tablet 6% above median
MOXOLENE Moxifloxacin 0.5 % Ophthalmic drops 5ml 072875 PKR 567.96 PKR 113.59/mL Near median
MOXOLENE Moxifloxacin 0.5 % Ophthalmic drops 3ml 072875 PKR 340.78 PKR 113.59/mL Near median
MYOBID Ofloxacin 200 mg Tablet 10 044643 PKR 237.51 PKR 23.75/tablet 6% above median
MYOBID Ofloxacin 400 mg Tablet 10 059423 PKR 309.80 PKR 30.98/tablet 6% above median
NA-ZOLE Fluconazole 150 mg Capsule 1 050180 PKR 285.01 PKR 285.01/capsule 9% above median
NA-ZOLE Fluconazole 50 mg/5 mL Dry suspension 35ml 082485 PKR 418.89 PKR 11.97/mL Near median
NEEDOX Ciprofloxacin 250 mg Tablet 10 044639 PKR 268.49 PKR 26.85/tablet 5% above median
NEEDOX Ciprofloxacin 500 mg Tablet 10 044640 PKR 536.98 PKR 53.70/tablet 26% above median
NEEDOX Ciprofloxacin 250 mg/5 mL Suspension 60ml 072757 PKR 206.53 PKR 3.44/mL 34% below median
NEEDOX Ciprofloxacin 125 mg/5 mL Suspension 60ml 072959 PKR 119.78 PKR 2.00/mL 43% below median
NEEDOX Ciprofloxacin 0.3 % Ophthalmic drops 5ml 072966 PKR 196.20 PKR 39.24/mL Near median
Needox Eacht Ciprofloxacin 750 mg Tablet 10 054953 PKR 413.06 PKR 41.31/tablet Near median
OLAPAN Olanzapine 10 mg Tablet 10 050172 PKR 309.80 PKR 30.98/tablet Near median
OLAPAN Olanzapine 5 mg Tablet 10 050175 PKR 175.55 PKR 17.56/tablet Near median
ONITRON Ondansetron 8 mg Tablet 10 083499 PKR 1,776.16 PKR 177.62/tablet 6% above median
OREXIM Cefixime 200 mg Capsule 5 046183 PKR 340.78 PKR 68.16/capsule 9% above median
OREXIM Cefixime 400 mg Capsule 5 046184 PKR 592.04 PKR 118.41/capsule Near median
OREXIM Cefixime 100 mg/5 mL Suspension 30ml 046193 PKR 330.39 PKR 11.01/mL Near median
OREXIM DS Cefixime 200 mg/5 mL Dry suspension 30ml 046194 PKR 404.32 PKR 13.48/mL Near median
QUINOPAN Hydroxychloroquine 200 mg Tablet 50 106070 PKR 722.58 PKR 14.45/tablet Near median
QUINOPAN Hydroxychloroquine 200 mg Tablet 30 106070 PKR 433.55 PKR 14.45/tablet Near median
QUTEC Quetiapine 100 mg Tablet 30 065468 PKR 2,230.53 PKR 74.35/tablet Near median
QUTEC Quetiapine 100 mg Tablet 10 065468 PKR 743.51 PKR 74.35/tablet Near median
QUTEC Quetiapine 200 mg Tablet 30 065469 PKR 2,065.30 PKR 68.84/tablet 26% below median
QUTEC Quetiapine 200 mg Tablet 10 065469 PKR 687.75 PKR 68.78/tablet 26% below median
QUTEC Quetiapine 25 mg Tablet 10 099756 PKR 160.57 PKR 16.06/tablet 24% below median
QUTEC Quetiapine 25 mg Tablet 30 099756 PKR 481.72 PKR 16.06/tablet 24% below median
QUTEC Quetiapine 25 mg Tablet 20 099756 PKR 321.15 PKR 16.06/tablet 24% below median
QUTEC XR Quetiapine 300 mg Tablet 10 097755 PKR 1,040.51 PKR 104.05/tablet 23% below median
RESTOP Risperidone 2 mg Tablet 10 048309 PKR 402.73 PKR 40.27/tablet 10% above median
RESTOP Risperidone 4 mg Tablet 10 048310 PKR 805.47 PKR 80.55/tablet 11% above median
RESTOP Risperidone 1 mg Tablet 10 059427 PKR 247.84 PKR 24.78/tablet 6% above median
RESTOP Risperidone 3 mg Tablet 10 062351 PKR 619.59 PKR 61.96/tablet 6% above median
Rolla 1gm Injection IVRegistry verified Meropenem (as Trihydrate) — — — 134068Official source ↗ No indexed price — —
Rolla 500mg Injection IVRegistry verified Meropenem (as Trihydrate) — — — 134067Official source ↗ No indexed price — —
SARTX Losartan 50 mg Tablet 20 059428 PKR 413.06 PKR 20.65/tablet Near median
TERBISER Terbinafine 125 mg Tablet 10 063209 PKR 646.44 PKR 64.64/tablet 25% above median
TERBISER FORTE Terbinafine 250 mg Tablet 10 083494 PKR 1,032.65 PKR 103.27/tablet 27% above median
TERBISER w/w Terbinafine 1 % Cream 10gm 072770 PKR 294.42 PKR 29.44/g Near median
TERIZOLE Itraconazole 100 mg Capsule 4 081423 PKR 619.59 PKR 154.90/capsule 7% above median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Panacea Pharmaceuticals — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 26, 2026, from https://medinfobase.com/company/panacea-pharmaceuticals/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.